ClinicalTrials.govpublic full text
A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients
hiv infections, drug therapy, combination, hiv protease inhibitors, lamivudine, carbohydrates, vx 478, reverse transcriptase inhibitors, anti-hiv agents, lipids, insulin resistance, abacavir, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 825782
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.